Publicaciones en las que colabora con María del Carmen González García (19)

2016

  1. Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice

    Vascular Pharmacology, Vol. 77, pp. 38-47

2015

  1. Fetal undernutrition is associated with perinatal sex-dependent alterations in oxidative status

    Journal of Nutritional Biochemistry, Vol. 26, Núm. 12, pp. 1650-1659

  2. Genetic predisposition to albuminuria is associated with increased arterial stiffness: Role of elastin

    British Journal of Pharmacology, Vol. 172, Núm. 17, pp. 4406-4418

2014

  1. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat diet-derived endothelial dysfunction

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. Remodeling of energy metabolism and absence of electrophysiological changes in the heart of obese hyperleptinemic mice. New insights into the pleiotropic role of leptin

    Frontiers in Endocrinology, Vol. 4, Núm. NOV

2012

  1. Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension

    Frontiers in Pharmacology, Vol. 3 JUN

2010

  1. Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity

    Endocrinology, Vol. 151, Núm. 7, pp. 3299-3306

2008

  1. A reduction in the amount and anti-contractile effect of periadventitial mesenteric adipose tissue precedes hypertension development in spontaneously hypertensive rats

    Hypertension Research, Vol. 31, Núm. 7, pp. 1415-1423

  2. Hypertension increases middle cerebral artery resting tone in spontaneously hypertensive rats: Role of tonic vasoactive factor availability

    Clinical Science, Vol. 114, Núm. 9-10, pp. 651-659

2006

  1. Short-term treatment of spontaneously hypertensive rats with liver growth factor reduces carotid artery fibrosis, improves vascular function, and lowers blood pressure

    Cardiovascular Research, Vol. 69, Núm. 3, pp. 764-771

  2. Vasodilatory effects of cholecystokinin: New role for an old peptide?

    Regulatory Peptides, Vol. 137, Núm. 3, pp. 179-184

2005

  1. Modulatory role of the adventitia on noradrenaline and angiotensin II responses: Role of endothelium and AT 2 receptors

    Cardiovascular Research, Vol. 65, Núm. 2, pp. 478-486

2004

  1. A novel role for cholecystokinin: Regulation of mesenteric vascular resistance

    Regulatory Peptides, Vol. 121, Núm. 1-3, pp. 145-153

2003

  1. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: New implications for the pathophysiology of panic

    Journal of Cerebral Blood Flow and Metabolism, Vol. 23, Núm. 3, pp. 364-370

2001

  1. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.

    Hypertension, Vol. 37, Núm. 5

  2. Effect of removal of adventitia on vascular smooth muscle contraction and relaxation

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 280, Núm. 6 49-6

  3. The upregulation of angiotensin-converting enzyme during neointima formation does not have functional consequences

    Life Sciences, Vol. 69, Núm. 16, pp. 1851-1860

1999

  1. Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems?

    Journal of Hypertension, Vol. 17, Núm. 10, pp. 1355-1361

1998

  1. Modulation of angiotensin-converting enzyme by nitric oxide

    British Journal of Pharmacology, Vol. 124, Núm. 2, pp. 291-298